Opus Genetics, Inc. 8-K

What Happened
Opus Genetics, Inc. (a Delaware corporation) filed a Form 8-K on January 8, 2026 under Item 7.01 (Regulation FD Disclosure) to furnish a press release titled “Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts.” The press release was furnished as Exhibit 99.1 to the filing.

Key Details

• Filing date: January 8, 2026.
• Disclosure type: Item 7.01 — Regulation FD Disclosure (press release furnished).
• Exhibit provided: 99.1 (Press Release).
• The filing does not report financial statements, officer changes, or material agreements in this 8-K.

Why It Matters
This filing signals the company publicly summarized its 2025 progress and identified planned catalysts for 2026, which could help investors assess near-term milestones and corporate priorities. Because this is a Regulation FD disclosure (a press release furnished as an exhibit) rather than an earnings report or itemizing material contracts or personnel changes, investors should read the attached press release for specifics and watch for follow-up filings (e.g., Form 10-Q, 8-Ks with material developments) for financial or operational details.